Journal ArticleDOI
“Atherogenic index of plasma” (log10 triglyceride/high-density lipoprotein−cholesterol) predicts high blood pressure, diabetes, and vascular events
Reads0
Chats0
TLDR
High AIP, a surrogate of small LDL particle size, reflects obesity and hyperinsulinemia in men and high CRP status in women, and predicted diabetes and high blood pressure in both sexes after adjustment for age and CRP.About:
This article is published in Journal of Clinical Lipidology.The article was published on 2010-03-01. It has received 251 citations till now. The article focuses on the topics: Metabolic syndrome & Type 2 diabetes.read more
Citations
More filters
Journal ArticleDOI
Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association
Harold E. Bays,Peter P. Toth,Penny M. Kris-Etherton,Nicola Abate,Louis J. Aronne,W. Virgil Brown,J. Michael Gonzalez-Campoy,Steven R. Jones,Rekha B. Kumar,Ralph La Forge,Varman T. Samuel +10 more
TL;DR: On September 16, 2012, the National Lipid Association held a Consensus Conference with the goal of better defining the effect of adiposity on lipoproteins, how the pathos of excessive body fat (adiposopathy) contributes to dyslipidemia, and how therapies such as appropriate nutrition, increased physical activity, weight-management drugs, and bariatric surgery might be expected to impact dys Lipidemia.
Journal ArticleDOI
Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography
TL;DR: FERHDL and AIP reflect the actual composition of the lipoprotein spectrum and thus predict both the cardiovascular risk and effectiveness of therapy and are available for use in clinical practice as it can be readily calculated from the routine lipid profile.
Journal ArticleDOI
The atherogenic index of plasma is a strong and independent predictor for coronary artery disease in the Chinese Han population.
TL;DR: The atherogenic index of plasma (AIP), a new comprehensive lipid index, might be a strong marker for predicting the risk of CAD in the Chinese Han population and was an independent risk factor for CAD.
Journal ArticleDOI
Residual macrovascular risk in 2013: what have we learned?
Jean-Charles Fruchart,Jean-Luc Davignon,Michel P. Hermans,Khalid Al-Rubeaan,Pierre Amarenco,Gerd Assmann,Philip J. Barter,John Betteridge,Eric Bruckert,Ada Cuevas,Michel Farnier,Ele Ferrannini,Paola Fioretto,Jacques Genest,Henry N. Ginsberg,Antonio M. Gotto,Dayi Hu,Takashi Kadowaki,Tatsuhiko Kodama,Michel Krempf,Yuji Matsuzawa,Jesús Millán Núñez-Cortés,Carlos Calvo Monfil,Hisao Ogawa,Jorge Plutzky,Daniel J. Rader,Shaukat Sadikot,Raul D. Santos,Evgeny Shlyakhto,Piyamitr Sritara,Rody G. Sy,Alan R. Tall,Chee Eng Tan,Lale Tokgozoglu,Peter P. Toth,Paul Valensi,Christoph Wanner,Alberto Zambon,Junren Zhu,Paul Zimmet +39 more
TL;DR: Monitoring of non-HDL cholesterol provides a simple, practical tool for treatment decisions regarding the management of lipid-related residual cardiovascular risk, and several emerging treatments may offer promise.
Journal ArticleDOI
Triglyceride to HDL-C Ratio and Increased Arterial Stiffness in Children, Adolescents, and Young Adults
Elaine M. Urbina,Philip R. Khoury,Connie E McCoy,Lawrence M. Dolan,Stephen R. Daniels,Thomas R. Kimball +5 more
TL;DR: In this article, the authors tested whether triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C) was an independent predictor of arterial stiffness in youth.
References
More filters
Journal ArticleDOI
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Scott M. Grundy,David W. Bilheimer,Alan Chait,Luther T. Clark,Margo A. Denke,Richard J. Havel,William R. Hazzard,Stephen B. Hulley,Donald B. Hunninghake,Robert A. Kreisberg,Penny M. Kris-Etherton,James M. McKenney,Michael A. Newman,Ernst J. Schaefer,Burton E. Sobel,Carolyn Somelofski,Milton C. Weinstein,H. Bryan Brewer,James I. Cleeman,Karen A. Donato,Nancy D. Ernst,Jeffrey M. Hoeg,Basil M. Rifkind,Jacques E. Rossouw,Christopher T. Sempos,Joanne M. Gallivan,Maureen N. Harris,Laurie Quint-Adler +27 more
TL;DR: Dairy therapy remains the first line of treatment of high blood cholesterol, and drug therapy is reserved for patients who are considered to be at high risk for CHD, and the fundamental approach to treatment is comparable.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National
William C. Taylor,Nigel Unwin +1 more
Journal ArticleDOI
Report of the expert committee on the diagnosis and classification of diabetes mellitus
James R. Gavin,K. G M M Alberti,Mayer B. Davidson,Ralph A. DeFronzo,Allan Drash,Steven G. Gabbe,Saul M. Genuth,Maureen I. Harris,Richard Kahn,Harry Keen,William C. Knowler,Harold E. Lebovitz,Noel K. Maclaren,Jerry P. Palmer,Philip Raskin,Robert A. Rizza,Michael P. Stern +16 more
TL;DR: It was deemed essential to develop an appropriate, uniform terminology and a functional, working classification of diabetes that reflects the current knowledge about the disease.
Journal ArticleDOI
Definition of Metabolic Syndrome Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition
TL;DR: Although ATP III identified CVD as the primary clinical outcome of the metabolic syndrome, most people with this syndrome have insulin resistance, which confers increased risk for type 2 diabetes, when diabetes becomes clinically apparent, CVD risk rises sharply.
Journal ArticleDOI
Follow-up report on the diagnosis of diabetes mellitus.
Saul Genuth,K. G. M. M. Alberti,Peter H. Bennett,John B. Buse,Ralph A. DeFronzo,Richard Kahn,John L. Kitzmiller,William C. Knowler,Harold E. Lebovitz,Åke Lernmark,David M. Nathan,Jerry P. Palmer,Robbert Rizza,Christopher D Saudek,Jonathan E. Shaw,Michael W. Steffes,Michael P. Stern,Jaakko Tuomilehto,Paul Zimmet +18 more
TL;DR: The International Expert Committee was convened to reexamine the classification and diagnostic criteria of diabetes, which were based on the 1979 publication of the National Diabetes Data Group and subsequent WHO study group and adopted several changes to the diagnostic criteria for diabetes and for lesser degrees of impaired glucose regulation (IFG/IGT).
Related Papers (5)
The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FERHDL)
M. Dobiasova,Jiri Frohlich +1 more
Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Scott M. Grundy,David W. Bilheimer,Alan Chait,Luther T. Clark,Margo A. Denke,Richard J. Havel,William R. Hazzard,Stephen B. Hulley,Donald B. Hunninghake,Robert A. Kreisberg,Penny M. Kris-Etherton,James M. McKenney,Michael A. Newman,Ernst J. Schaefer,Burton E. Sobel,Carolyn Somelofski,Milton C. Weinstein,H. Bryan Brewer,James I. Cleeman,Karen A. Donato,Nancy D. Ernst,Jeffrey M. Hoeg,Basil M. Rifkind,Jacques E. Rossouw,Christopher T. Sempos,Joanne M. Gallivan,Maureen N. Harris,Laurie Quint-Adler +27 more